Discover how AOD supports muscle regeneration and combats muscle wasting in cachexia and sarcopenia. Learn its molecular mechanism, research-backed benefits, and therapeutic...
Learn how NAD⁺ fuels DNA repair, strengthens mitochondrial function, and protects against aging and cancer. Explore the science behind the NAD⁺/sirtuin axis...
Sermorelin is a clinically researched peptide that boosts natural growth hormone (GH) and IGF-1 production, supporting brain health, memory, and cognitive performance....
Tirzepatide is a revolutionary dual incretin peptide that activates both GIP and GLP-1 receptors, thereby improving insulin secretion, reducing glucagon secretion, and...
Retatrutide marks a groundbreaking advancement in peptide therapeutics with its triple agonist mechanism that targets GLP-1, GIP, and glucagon receptors. By enhancing...
TB-500 is gaining attention as a groundbreaking peptide for research on chronic inflammation and tissue repair. This comprehensive blog examines the mechanism...
Melanotan II is a synthetic analogue of alpha-MSH known to influence pigmentation, energy balance, and sexual desire. This blog explores its mechanism,...
NAD⁺ is essential for mitochondrial energy production and neuronal survival, making it a critical focus in Parkinson’s disease research. This blog explains...
Cagrilintide is a novel peptide showing strong potential in preventing type 2 diabetes among high-risk patients. By reducing body weight, especially visceral...
BPC-157 is a promising peptide known for its ability to accelerate the healing of muscles, tendons, and ligaments while reducing inflammation. Despite...
Tirzepatide is redefining obesity and diabetes treatment with its dual GLP-1 and GIP receptor action. Clinical trials highlight remarkable weight loss, improved...
Retatrutide is advancing cardiometabolic research by significantly reducing cardiovascular risk factors. It lowers non-HDL cholesterol, triglycerides, and LDL particles while promoting substantial...
TB-500, a synthetic peptide, shows promising preclinical evidence in promoting tissue repair and reducing fibrosis in lung injury models. Its role in...
GHK-Cu is a bioactive copper peptide shown to accelerate healing and improve outcomes after transplantation. It enhances collagen production, reduces inflammation, protects...
Retatrutide is a groundbreaking triple receptor agonist transforming research in obesity, diabetes, liver disease, cardiovascular health, inflammation, and aging. Discover its broader...
TB-500, a synthetic peptide derived from Thymosin Beta-4, shows promising potential in repairing nerve and vascular damage in peripheral neuropathy. Preclinical studies...
Melanotan II, a synthetic analog of α-melanocyte-stimulating hormone, activates melanocortin receptors to regulate pigmentation and appetite. Its pharmacology provides valuable insights into...
NAD+ is vital for energy metabolism, DNA repair, and cellular health, directly shaping the aging process. Its decline accelerates cellular dysfunction and...
BPC-157 offers a groundbreaking approach to osteoarthritis, targeting inflammation, vascularization, and cartilage regeneration. Prime Lab Peptides provides research-backed protocols for precise dosing...
Tirzepatide, a dual GIP and GLP-1 receptor agonist, offers breakthrough metabolic therapy by significantly improving glycemic control and promoting substantial weight loss....
GHK-Cu, a copper-binding tripeptide, plays a critical role in skin regeneration and wound healing by stimulating collagen synthesis, reducing inflammation, and enhancing...
Explore retatrutide’s advanced molecular design and clinical efficacy in addressing obesity, type 2 diabetes, and metabolic disorders. This blog delves into its...
Cagrilintide, a next-generation amylin analog peptide, offers promising advances in obesity treatment by targeting brain hunger pathways. This blog explores its unique...
Retatrutide is a groundbreaking triple agonist targeting GLP-1, GIP, and glucagon receptors to revolutionize obesity and metabolic disease treatment. Early trials show...
Melanotan II (MTII) is a potent α-MSH analogue that has transformed pigmentation research. From enhancing eumelanin production and photoprotection to influencing DNA...
Tirzepatide is a novel dual GLP-1 and GIP receptor agonist offering groundbreaking improvements in type 2 diabetes and obesity management. By simultaneously...
GHK-Cu, a powerful copper peptide, is transforming wound healing and inflammation management. Backed by clinical research, it stimulates collagen, repairs tissue, and...
TB-500 is a synthetic peptide inspired by Thymosin Beta-4, a naturally occurring protein involved in cell migration and tissue repair. Emerging research...
BPC-157 is a synthetic peptide gaining attention for its powerful healing potential. Research highlights its ability to support muscle, tendon, and gut...
Cagrilintide is a groundbreaking obesity therapy targeting amylin receptors to suppress appetite and reduce fat mass while preserving lean muscle. Combined with...
Retatrutide is an innovative triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, offering a promising approach for obesity and type 2...
All products offered by Prime Lab Peptides are intended strictly for laboratory research and development purposes. These materials are not designed or approved for human or animal use, and must not be utilized for any diagnostic, therapeutic, or medical application.
Prime Lab Peptides does not provide instructions related to preparation, reconstitution, administration, injection, dosage, or any form of usage.
No product sold on this website is classified as a drug, dietary supplement, or medical device under federal law.
All items are labeled “For Research Use Only – Not for Human or Animal Use,” in accordance with 21 CFR 809.10(c) and other applicable regulations.
Any misuse, diversion, or unauthorized application is strictly prohibited and may violate federal, state, or international laws.
Prime Lab Peptides operates solely as a chemical and research material supplier.
We are not a compounding pharmacy (503A) nor an outsourcing facility (503B) as defined under the Federal Food, Drug, and Cosmetic Act.
Our products have not been evaluated by the U.S. Food & Drug Administration.
By purchasing from this website, you confirm that you are a qualified researcher or institution and accept full responsibility for the safe handling, storage, and use of these materials.
“Tirzepatide”, “Semaglutide”, and “Retatrutide” are recognized International Nonproprietary Names (INN) established by the World Health Organization. As such, these names are not subject to trademark protection and are used solely to identify the underlying chemical substances.